This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.

Please submit a response by 04/01/2013 at 2:00 p.m.

Please see attached RFP solicitation for more information and specifics on this requirement.

NDC 61958-0101-1
Vistide (Cidofovir 75mg/ml)
UOM: VIAL
Quantity: 2,000

Clauses and provisions are included in the RFP in effect through Federal Acquisition Circular. These include all commercial item clauses in FAR 12.603.